REQUEST A DEMO
Total
USD $0.00
Search more companies

Deepin Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Deepin Pharmaceuticals Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Deepin Pharmaceuticals Private Limited is an unlisted company, incorporated on 25/07/1996. It has its registered office in the State of Madhya Pradesh, India. Company's corporate identification number (CIN) is U24232MP1996PTC011048 and registration number is 011048. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
47-A,Prem-Nagar,Manik-Bag-Road Indore
Indore; Madhya Pradesh; Postal Code: 452001

Contact Details: Purchase the Deepin Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Deepin Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Deepin Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Deepin Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
July 25, 1996
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Deepin Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-37.16%
Total operating revenue
-37.24%
Operating profit (EBIT)
-65.92%
EBITDA
-42.14%
Net Profit (Loss) for the Period
-70.06%
Total assets
-2.42%
Total equity
0.54%
Operating Profit Margin (ROS)
-0.74%
Net Profit Margin
-0.79%
Return on Equity (ROE)
-4.71%
Debt to Equity Ratio
19.05%
Quick Ratio
0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?